{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:42Z","timestamp":1788174762189,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00834-7","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:49:41Z","timestamp":1735868981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical effectiveness and safety comparison between direct oral anticoagulants and warfarin for nonvalvular atrial fibrillation patients following percutaneous left atrial appendage closure operation intervention: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yao","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"834_CR1","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","volume":"10","author":"H Huang","year":"2017","unstructured":"Huang H, Liu Y, Xu YW, Wang ZL, Li YG, Cao KJ, Zhang S, Yang YZ, Yang XC, Huang DJ, et al. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation a prospective, multicenter clinical study. JACC Cardiovasc Interv 2017;10:2188\u201394.","journal-title":"JACC Cardiovasc Interv"},{"key":"834_CR2","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, et al. 5-Year outcomes after Left atrial appendage closure from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 2017;70:2964\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"834_CR3","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","volume":"75","author":"P Osmancik","year":"2020","unstructured":"Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol 2020;75:3122\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"834_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, Investigators PA. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"issue":"9","key":"834_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, Doshi SK, Swarup V, Gibson DN, Maini B, Gordon NT, Main ML, Reddy VY. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138(9):874\u201385.","journal-title":"Circulation"},{"key":"834_CR6","doi-asserted-by":"publisher","first-page":"E1019","DOI":"10.1002\/ccd.29458","volume":"97","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A, Nickenig G, Schrickel JW, Ince H, Schmidt B, Protopopov AV, Betts TR, Gori T, Sievert H, Mazzone P, et al. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry. Catheter Cardiovasc Interv 2021;97:E1019\u2013e1024.","journal-title":"Catheter Cardiovasc Interv"},{"key":"834_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T, Jung RG, Lehenbauer K, Piayda K, Praco\u0144 R, Jackson GG, Flores-Umanzor E, Faroux L, Korsholm K, Chun JKR, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol 2021;78:297\u2013313.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"834_CR8","doi-asserted-by":"publisher","first-page":"E216","DOI":"10.1002\/ccd.27135","volume":"92","author":"M Lempereur","year":"2018","unstructured":"Lempereur M, Aminian A, Saw J. Rebuttal with regards to \u201cDevice-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet\u201d. Catheter Cardiovasc Interv. 2018;92(3):E216\u2013e217.","journal-title":"Catheter Cardiovasc Interv"},{"key":"834_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S, Fatemi M, Franceschi F, Guedeney P, Jacon P, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 2018;71:1528\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"834_CR10","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","volume":"41","author":"D Hildick-Smith","year":"2020","unstructured":"Hildick-Smith D, Landmesser U, Camm AJ, Diener HC, Paul V, Schmidt B, Settergren M, Teiger E, Nielsen-Kudsk JE, Tondo C. Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study. Eur Heart J. 2020;41(30):2894\u2013901.","journal-title":"Eur Heart J"},{"key":"834_CR11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/ehjci\/jey010","volume":"19","author":"H Cochet","year":"2018","unstructured":"Cochet H, Iriart X, Sridi S, Camaioni C, Corneloup O, Montaudon M, Laurent F, Selmi W, Renou P, Jalal Z, et al. Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study. Eur Heart J Cardiovasc Imaging 2018;19:1351\u201361.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"834_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jacep.2017.05.006","volume":"3","author":"S Kubo","year":"2017","unstructured":"Kubo S, Mizutani Y, Meemook K, Nakajima Y, Hussaini A, Kar S. Incidence, characteristics, and clinical course of device-related thrombus after watchman left atrial appendage occlusion device implantation in atrial fibrillation patients. JACC Clin Electrophysiol. 2017;3(12):1380\u201386.","journal-title":"JACC Clin Electrophysiol"},{"key":"834_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","volume":"15","author":"M Glikson","year":"2020","unstructured":"Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, Fauchier L, Betts TR, Lewalter T, Saw J, et al. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. Eurointervention 2020;15:1133\u2013+.","journal-title":"Eurointervention"},{"issue":"10","key":"834_CR14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/europace\/euu174","volume":"16","author":"B Meier","year":"2014","unstructured":"Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014;16(10):1397\u2013416.","journal-title":"Europace"},{"issue":"3","key":"834_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jth.13595","volume":"15","author":"A Achilles","year":"2017","unstructured":"Achilles A, Mohring A, Dannenberg L, Grandoch M, Hohlfeld T, Fischer JW, Levkau B, Kelm M, Zeus T, Polzin A. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation. J Thromb Haemost. 2017;15(3):473\u201376.","journal-title":"J Thromb Haemost"},{"key":"834_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.119.315099","volume":"126","author":"T Petzold","year":"2020","unstructured":"Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M\u2019Pembele R, Achilles A, Trojovky K, Konsek D, et al. Rivaroxaban reduces arterial thrombosis by inhibition of FXa-Driven platelet activation via protease activated receptor-1. Circ Res 2020;126:486\u2013500.","journal-title":"Circ Res"},{"key":"834_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","volume":"14","author":"LV Boersma","year":"2017","unstructured":"Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm 2017;14:1302\u201308.","journal-title":"Heart Rhythm"},{"key":"834_CR18","doi-asserted-by":"publisher","first-page":"e012183","DOI":"10.1161\/CIRCINTERVENTIONS.122.012183","volume":"15","author":"A Sandhu","year":"2022","unstructured":"Sandhu A, Varosy PD, Du C, Aleong RG, Tumolo AZ, West JJ, Tzou WS, Curtis JP, Freeman JV, Friedman DJ, et al. Device-sizing and associated complications with left atrial appendage occlusion: findings from the NCDR LAAO Registry. Circ Cardiovasc Interv 2022;15:e012183.","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"834_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacep.2021.10.001","volume":"8","author":"MK Turagam","year":"2022","unstructured":"Turagam MK, Neuzil P, Hala P, Mraz T, Dukkipati SR, Reddy VY. Intracardiac echocardiography-guided left atrial appendage closure with a novel foam-based conformable device safety and 1-year outcomes. JACC Clin Electrophysiol. 2022;8(2):197\u2013207.","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"834_CR20","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"AC Spyropoulos","year":"2019","unstructured":"Spyropoulos AC, Brohi K, Caprini J, Samama CM, Siegal D, Tafur A, Verhamme P, Douketis JD. Scientific and Standardization Committee Communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019;17(11):1966\u201372.","journal-title":"J Thromb Haemost"},{"key":"834_CR21","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","volume":"14","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG, Magnocavallo M, Di Biase L, Mohanty S, Trivedi C, Tarantino N, Gianni C, Lavalle C, Van Niekerk CJ, Romero J, et al. Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion. JACC Cardiovasc Interv 2021;14:2353\u201364.","journal-title":"JACC Cardiovasc Interv"},{"key":"834_CR22","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","volume":"14","author":"DGD Rocca","year":"2021","unstructured":"Rocca DGD, Magnocavallo M, Biase LD, Mohanty S, Trivedi C, Tarantino N, Gianni C, Lavalle C, Niekerk CJV, Romero J, et al. Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion. JACC Cardiovasc Interv 2021;14:2353\u201364.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"834_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4085\/1062-6050-43.2.215","volume":"43","author":"M Kang","year":"2008","unstructured":"Kang M, Ragan BG, Park JH. Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train. 2008;43(2):215\u201321.","journal-title":"J Athl Train"},{"key":"834_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.carrev.2021.11.007","volume":"40","author":"E Flores-Umanzor","year":"2022","unstructured":"Flores-Umanzor E, Cepas-Guillen P, Regueiro A, Sanchis L, Unigarro F, Brugaletta S, Sitges M, Sabate M, Freixa X. Treatment of device-related thrombosis after left atrial appendage occlusion: initial experience with low-dose apixaban. Cardiovasc Revasc Med. 2022;40:201\u201303.","journal-title":"Cardiovasc Revasc Med"},{"issue":"11","key":"834_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","volume":"12","author":"J Saw","year":"2019","unstructured":"Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS. Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure. JACC Cardiovasc Interv. 2019;12(11):1067\u201376.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"834_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/europace\/eus413","volume":"15","author":"GY Lip","year":"2013","unstructured":"Lip GY, Dagres N, Proclemer A, Svendsen JH, Pison L, Blomstrom-Lundqvist C. Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Europace. 2013;15(1):141\u201343.","journal-title":"Europace"},{"issue":"13","key":"834_CR27","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jacc.2007.02.035","volume":"49","author":"PB Sick","year":"2007","unstructured":"Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49(13):1490\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"834_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"issue":"1","key":"834_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr","year":"2014","unstructured":"Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"834_CR30","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, M\u00f6bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013;61(25):2551\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"834_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","volume":"13","author":"MW Bergmann","year":"2017","unstructured":"Bergmann MW, Betts TR, Sievert H, Schmidt B, Pokushalov E, Kische S, Schmitz T, Meincke F, Stein KM, Boersma LVA, et al. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. EuroIntervention 2017;13:877\u201384.","journal-title":"EuroIntervention"},{"key":"834_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.hrthm.2023.01.007","volume":"20","author":"J Saw","year":"2023","unstructured":"Saw J, Holmes DR, Cavalcante JL, Freeman JV, Goldsweig AM, Kavinsky CJ, Moussa ID, Munger TM, Price MJ, Reisman M, et al. SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure. Heart Rhythm 2023;20:e1\u2013e16.","journal-title":"Heart Rhythm"},{"issue":"12","key":"834_CR33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/clc.22478","volume":"38","author":"LI B\u00f6sche","year":"2015","unstructured":"B\u00f6sche LI, Afshari F, Sch\u00f6ne D, Ewers A, M\u00fcgge A, Gotzmann M. Initial experience with novel oral anticoagulants during the first 45 days after left atrial appendage closure with the Watchman device. Clin Cardiol. 2015;38(12):720\u201324.","journal-title":"Clin Cardiol"},{"key":"834_CR34","doi-asserted-by":"publisher","first-page":"4405152","DOI":"10.1155\/2024\/4405152","volume":"2024","author":"Y Yao","year":"2024","unstructured":"Yao Y, Li Y, Jin Q, Li X, Zhang X, Lv Q. Perioperative treatment with rivaroxaban and dabigatran on changes of coagulation and platelet activation biomarkers following left atrial appendage closure. Cardiovasc Ther. 2024;2024:4405152.","journal-title":"Cardiovasc Ther"},{"issue":"21","key":"834_CR35","doi-asserted-by":"publisher","first-page":"e013053","DOI":"10.1161\/JAHA.119.013053","volume":"8","author":"YH Chan","year":"2019","unstructured":"Chan YH, Lee HF, Wang CL, Chang SH, Yeh CH, Chao TF, Yeh YH, Chen SA, Kuo CT. Comparisons of rivaroxaban following different dosage criteria (ROCKET AF or J-ROCKET AF Trials) in Asian patients with atrial fibrillation. J Am Heart Assoc. 2019;8(21):e013053.","journal-title":"J Am Heart Assoc"},{"key":"834_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hrthm.2016.10.020","volume":"14","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Gadiyaram VK, Gianni C, Horton RP, Trivedi C, Mohanty S, Di Biase L, Al-Ahmad A, Burkhardt JD, Narula A, et al. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. Heart Rhythm 2017;14:19\u201324.","journal-title":"Heart Rhythm"},{"issue":"8","key":"834_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jfma.2021.10.015","volume":"121","author":"GH Fu","year":"2022","unstructured":"Fu GH, Wang BH, He B, Yu YB, Wang Z, Feng MJ, Liu J, Du XF, Zhuo WD, Chu HM. Original Article Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device. J Formos Med Assoc. 2022;121(8):1488\u201394.","journal-title":"J Formos Med Assoc"},{"key":"834_CR38","doi-asserted-by":"publisher","first-page":"614762","DOI":"10.3389\/fphar.2021.614762","volume":"12","author":"XY Li","year":"2021","unstructured":"Li XY, Zhang XC, Jin QC, Xue Y, Lu WJ, Ge JB, Zhou DX, Lv QZ. Clinical efficacy and safety comparison of rivaroxaban and dabigatran for nonvalvular atrial fibrillation patients undergoing percutaneous left atrial appendage closure operation. Front Pharmacol. 2021;12:614762.","journal-title":"Front Pharmacol"},{"key":"834_CR39","doi-asserted-by":"publisher","first-page":"723905","DOI":"10.3389\/fphar.2021.723905","volume":"12","author":"XY Li","year":"2021","unstructured":"Li XY, Zhang XC, Jin QC, Li YL, Zhou DX, Lv QZ, Ge JB. The impact of dabigatran and rivaroxaban on variation of platelet activation biomarkers and DRT following percutaneous left atrial appendage closure. Front Pharmacol. 2021;12:723905.","journal-title":"Front Pharmacol"},{"issue":"6","key":"834_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1074248415578172","volume":"20","author":"E Perzborn","year":"2015","unstructured":"Perzborn E, Heitmeier S, Laux V. Effects of rivaroxaban on platelet activation and platelet-coagulation pathway interaction: in vitro and in vivo studies. J Cardiovasc Pharmacol Ther. 2015;20(6):554\u201362.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"2","key":"834_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11239-017-1512-2","volume":"44","author":"PJ Vinholt","year":"2017","unstructured":"Vinholt PJ, Nielsen C, Sderstrm AC, Brandes A, Nybo M. Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner. J Thromb Thrombolysis. 2017;44(2):216\u201322.","journal-title":"J Thromb Thrombolysis"},{"key":"834_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.thromres.2022.12.007","volume":"222","author":"S Ono","year":"2023","unstructured":"Ono S, Ishimaru M, Yokota I, Konishi T, Okada A, Ono Y, Matsui H, Itai S, Yonenaga K, Tonosaki K, et al. Risk of post-extraction bleeding with direct oral anticoagulant compared with warfarin: retrospective cohort study using large scale claims data in Japan. Thrombosis Res. 2023;222:24\u201330.","journal-title":"Thrombosis Res"},{"key":"834_CR43","doi-asserted-by":"publisher","first-page":"E1019","DOI":"10.1002\/ccd.29458","volume":"97","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A, Nickenig G, Schrickel JW, Ince H, Schmidt B, Protopopov AV, Betts TR, Gori T, Sievert H, Mazzone P, et al. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry. Cathet Cardiovasc Interv 2021;97:E1019\u2013E1024.","journal-title":"Cathet Cardiovasc Interv"},{"key":"834_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","volume":"9","author":"B Schmidt","year":"2023","unstructured":"Schmidt B, Nielsen-Kudsk JE, Ellis CR, Thaler D, Sabir SA, Gambhir A, Landmesser U, Shah N, Gray W, Swarup V, et al. Incidence, predictors, and clinical outcomes of device-related thrombus in the amulet IDE trial. JACC Clin Electrophysiol 2023;9:96\u2013107.","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"834_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0002-9149(97)00903-X","volume":"81","author":"T Tabata","year":"1998","unstructured":"Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, Kitagawa T, Kato I, Kitahata H, Oshita S. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol. 1998;81(3):327\u201332.","journal-title":"Am J Cardiol"},{"issue":"1","key":"834_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccep.2019.11.004","volume":"12","author":"G Murtaza","year":"2020","unstructured":"Murtaza G, Yarlagadda B, Akella K, Della Rocca DG, Gopinathannair R, Natale A, Lakkireddy D. Role of the left atrial appendage in systemic homeostasis, arrhythmogenesis, and beyond. Card Electrophysiol Clin. 2020;12(1):21\u201328.","journal-title":"Card Electrophysiol Clin"},{"issue":"3","key":"834_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/archinte.167.3.229","volume":"167","author":"SE Kimmel","year":"2007","unstructured":"Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Gross R. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med. 2007;167(3):229\u201335.","journal-title":"Arch Intern Med"},{"key":"834_CR48","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","volume":"143","author":"S Kar","year":"2021","unstructured":"Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, Stone Jr J, Shah M, Dukkipati SR, Adler S, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation 2021;143:1754\u201362.","journal-title":"Circulation"},{"issue":"2","key":"834_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ccd.31111","volume":"104","author":"R Chatani","year":"2024","unstructured":"Chatani R, Kubo S, Tasaka H, Nishiura N, Mushiake K, Ono S, Maruo T, Kadota K. Transition from WATCHMAN generation-2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: incidence and predictors of device-related thrombosis and short- to mid-term outcomes. Catheter Cardiovasc Interv. 2024;104(2):318\u201329.","journal-title":"Catheter Cardiovasc Interv"},{"key":"834_CR50","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jacep.2023.04.013","volume":"9","author":"WI Saliba","year":"2023","unstructured":"Saliba WI, Kawai K, Sato Y, Kopesky E, Cheng Q, Ghosh SKB, Herbst TJ, Kawakami R, Konishi T, Virmani R, et al. Enhanced thromboresistance and endothelialization of a novel fluoropolymer-coated left atrial appendage closure device. JACC Clin Electrophysiol 2023;9:1555\u201367.","journal-title":"JACC Clin Electrophysiol"},{"issue":"22","key":"834_CR51","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","volume":"16","author":"M Alkhouli","year":"2023","unstructured":"Alkhouli M, Alarouri H, Kramer A, Korsholm K, Collins J, De Backer O, Hatoum H, Nielsen-Kudsk JE. Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management. JACC Cardiovasc Interv. 2023;16(22):2695\u2013707.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"834_CR52","doi-asserted-by":"publisher","first-page":"e008112","DOI":"10.1161\/CIRCINTERVENTIONS.119.008112","volume":"12","author":"K Korsholm","year":"2019","unstructured":"Korsholm K, Jensen JM, N\u00f8rgaard BL, Nielsen-Kudsk JE. Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography. Circ Cardiovasc Interv. 2019;12(9):e008112.","journal-title":"Circ Cardiovasc Interv"},{"key":"834_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ehjci\/jeac222","volume":"24","author":"AD Kramer","year":"2023","unstructured":"Kramer AD, Korsholm K, Jensen JM, N\u00f8rgaard BL, Peelukhana S, Herbst T, Horton R, Kar S, Saw J, Alkhouli M, et al. Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing? Eur Heart J Cardiovasc Imaging 2023;24:250\u201359.","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00834-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:03:22Z","timestamp":1735869802000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00834-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00834-7","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in accordance with the Declaration of Helsinki. The study received ethics approval from the Institutional Review Board (IRB) of Zhongshan Hospital, Fudan University, with the approval number B2020-288R. Signed informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the manuscript and provided their consent for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}